Brent Welborn

Title: Brent Welborn: Innovator in UV Light Exposure Methods

Introduction

Brent Welborn is a notable inventor based in Camarillo, CA (US). He has made significant contributions to the field of UV light exposure methods, holding 2 patents that address critical issues in this area. His work focuses on the inactivation of organisms and the preservation of protein integrity when exposed to UV light.

Latest Patents

Brent's latest patents include innovative methods for determining exposure to UV light. One patent outlines methods for determining the dose of UVC light delivered to a sample comprising a low optical transmission complex fluid. This patent also provides methods for inactivating organisms, such as spores, bacteria, or viruses, in such samples. Another patent focuses on methods for reducing or eliminating protein modification and degradation arising from UV light exposure. This includes techniques for inactivating viruses in protein-containing samples and methods to reduce oxidation of specific amino acid residues in proteins subjected to UV light.

Career Highlights

Brent Welborn is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in biotechnology and health.

Collaborations

Brent collaborates with talented coworkers, including Roger Hart and Amanda Lewis. Their combined expertise enhances the innovative environment at Amgen, fostering the development of groundbreaking technologies.

Conclusion

Brent Welborn's contributions to the field of UV light exposure methods demonstrate his commitment to innovation and scientific advancement. His patents not only address important health concerns but also pave the way for future research and development in biotechnology.